CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company focused on seeking to develop novel targeted medicines primarily for cancer treatment, today announced that the company will be presenting at BIO InvestorForum 2007, which is being held from October 9-11, 2007 at the Palace Hotel in San Francisco.
